Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The intestinal microflora imbalance has been associated with obesity and type 2 diabetes. The
researchers' study aimed to investigate the effect of saxagliptin on gut microbiota in
patients with newly diagnosed type 2 diabetes.